Mesenchymal Stem Cells Market Statistics | Forecast 2023-2032 

Mesenchymal Stem Cells Market Size - By Type (Autologous, Allogeneic), Source (Adipose Tissue, Bone Marrow), Indication (Bone & Cartilage Repair, Cardiovascular Diseases), Application & Global Forecast, 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Mesenchymal stem cells industry 360&ordm; synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Products &amp; services trends

2.1.4&nbsp;&nbsp;&nbsp; Type trends

2.1.5&nbsp;&nbsp;&nbsp; Source trends

2.1.6&nbsp;&nbsp;&nbsp; Indication trends

2.1.7&nbsp;&nbsp;&nbsp; Application trends

Chapter 3&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing awareness regarding regenerative medicine

3.2.1.2&nbsp;&nbsp;&nbsp;Evolving diverse applications of mesenchymal stem cells

3.2.1.3&nbsp;&nbsp;&nbsp;Rising prevalence of chronic diseases

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of associated with stem cell treatment

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of standardized &amp; regulated delivery of stem cell therapy

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By products &amp; services

3.3.2&nbsp;&nbsp;&nbsp; By type

3.3.3&nbsp;&nbsp;&nbsp; By source

3.3.4&nbsp;&nbsp;&nbsp; By indication

3.3.5&nbsp;&nbsp;&nbsp; By application

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Products &amp; Services, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by products &amp; services

5.2&nbsp;&nbsp;&nbsp; Products

5.2.1&nbsp;&nbsp;&nbsp; Kits, media, &amp; reagents

5.2.2&nbsp;&nbsp;&nbsp; Cells &amp; cell lines

5.2.3&nbsp;&nbsp;&nbsp; Other products

5.3&nbsp;&nbsp;&nbsp; Services

Chapter 6&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Type, 2018 - 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by type

6.2&nbsp;&nbsp;&nbsp; Autologous

6.3&nbsp;&nbsp;&nbsp; Allogeneic

Chapter 7&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Source, 2018 - 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by source

7.2&nbsp;&nbsp;&nbsp; Adipose tissue

7.3&nbsp;&nbsp;&nbsp; Bone marrow

7.4&nbsp;&nbsp;&nbsp; Cord blood

7.5&nbsp;&nbsp;&nbsp; Fetal liver

7.6&nbsp;&nbsp;&nbsp; Fallopian tube

7.7&nbsp;&nbsp;&nbsp; Lung

7.8&nbsp;&nbsp;&nbsp; Peripheral blood

7.9&nbsp;&nbsp;&nbsp; Other sources

Chapter 8&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Indication, 2018 - 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by indication

8.2&nbsp;&nbsp;&nbsp; Bone &amp; cartilage repair

8.3&nbsp;&nbsp;&nbsp; Cardiovascular diseases

8.4&nbsp;&nbsp;&nbsp; Inflammatory and immunological diseases

8.5&nbsp;&nbsp;&nbsp; Liver diseases

8.6&nbsp;&nbsp;&nbsp; Cancer

8.7&nbsp;&nbsp;&nbsp; Graft versus host disease (GvHD)

8.8&nbsp;&nbsp;&nbsp; Other indications

Chapter 9&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Application, 2018 - 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by application

9.2&nbsp;&nbsp;&nbsp; Disease modeling

9.3&nbsp;&nbsp;&nbsp; Drug development &amp; discovery

9.4&nbsp;&nbsp;&nbsp; Stem cell banking

9.5&nbsp;&nbsp;&nbsp; Tissue engineering

9.6&nbsp;&nbsp;&nbsp; Toxicology studies

9.7&nbsp;&nbsp;&nbsp; Other applications

Chapter 10&nbsp;&nbsp;&nbsp;Mesenchymal Stem Cells Market, By Region, 2018 - 2032 (USD Million)

10.1&nbsp;&nbsp;&nbsp; Key trends, by region

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; MEA

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

11.2&nbsp;&nbsp;&nbsp; Cell Applications, Inc.

11.3&nbsp;&nbsp;&nbsp; Cyagen Biosciences

11.4&nbsp;&nbsp;&nbsp; Axol Bioscience Ltd.

11.5&nbsp;&nbsp;&nbsp; Stemedica Cell Technologies, Inc.

11.6&nbsp;&nbsp;&nbsp; Merck KGaA

11.7&nbsp;&nbsp;&nbsp; Lonza

11.8&nbsp;&nbsp;&nbsp; Celprogen Inc.

11.9&nbsp;&nbsp;&nbsp; PromoCell GmbH

11.10&nbsp;&nbsp;&nbsp; STEMCELL Technologies 
&nbsp;

Mesenchymal Stem Cells Market

Get a free sample of this report